MT Newswires9d agoneutral
Goldman Sachs Adjusts Price Target on Bristol-Myers Squibb to $61 From $63News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3127last 7d
512● bullish (7d)
311● bearish (7d)
227publishers